Detalles de la búsqueda
1.
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.
Carcinogenesis
; 37(9): 852-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27381831
2.
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med
; 358(1): 36-46, 2008 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172173
3.
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.
Sci Rep
; 8(1): 1445, 2018 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29362371
4.
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
Lancet Haematol
; 5(5): e190-e200, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703335
5.
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
Eur J Cancer
; 41(11): 1551-9, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16026692
6.
Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
Int J Radiat Oncol Biol Phys
; 93(2): 303-12, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26031368
7.
TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.
J Natl Cancer Inst
; 106(7)2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24957073
8.
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease.
Clin Cancer Res
; 20(17): 4511-9, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24987061
9.
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
J Clin Oncol
; 30(14): 1620-7, 2012 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22473163
10.
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.
J Clin Oncol
; 28(25): 3945-50, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20679619
11.
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
J Clin Oncol
; 27(23): 3786-93, 2009 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19398575
12.
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
J Clin Oncol
; 24(4): 668-74, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16446339
Resultados
1 -
12
de 12
1
Próxima >
>>